Similar articles

• [Cytochemical changes in the peripheral blood leukocytes of guinea pigs inoculated against plague, tularemia and anthrax].

  Safronova VM, Loktev NA, Basilova GI, Pilipenko VG. Safronova VM, et al. Zh Mikrobiol Epidemiol Immunobiol. 1982 Jul;(7):73-6. Zh Mikrobiol Epidemiol Immunobiol. 1982. PMID: 6812331 Russian.
• [Current status of vaccine treatment of zoonotic infections].

  Lebedinskiĭ VA, Garin NS. Lebedinskiĭ VA, et al. Voen Med Zh. 1980 Sep;(9):47-50. Voen Med Zh. 1980. PMID: 6776687 Review. Russian. No abstract available.
• [Jet immunization with polyvalent vaccine against plague, tularemia, and anthrax].

  Loktev NA, Pilipenko VG, Basilova GI, Shchedrin VI, Lunina EA. Loktev NA, et al. Zh Mikrobiol Epidemiol Immunobiol. 1980 Jun;(6):109-10. Zh Mikrobiol Epidemiol Immunobiol. 1980. PMID: 7445856 Russian. No abstract available.
• [Aerosol vaccination against dangerous infectious diseases].

  Stepanov AV, Marinin LI, Vorob'ev AA. Stepanov AV, et al. Vestn Ross Akad Med Nauk. 1999;(8):47-54. Vestn Ross Akad Med Nauk. 1999. PMID: 10487124 Review. Russian.
• Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia.

  Jia Q, Bowen R, Dillon BJ, Masleša-Galić S, Chang BT, Kaidi AC, Horwitz MA. Jia Q, et al. Sci Rep. 2018 May 3;8(1):7009. doi: 10.1038/s41598-018-24581-y. Sci Rep. 2018. PMID: 29725025 Free PMC article.